1. Mutations in LPIN1 cause recurrent acute myoglobinuria in childhood
- Author
-
Yves de Keyzer, Avraham Zeharia, Pascale de Lonlay, Laurence Hubert, Ophry Pines, Avraham Shaag, Gideon Eshel, Orly Elpeleg, Gilli Erez, Tareq Hindi, Riekelt H. Houtkooper, Frédéric M. Vaz, Ann Saada, and Laboratory Genetic Metabolic Diseases
- Subjects
Male ,medicine.medical_specialty ,Phosphatidate Phosphatase ,medicine.disease_cause ,Models, Biological ,Rhabdomyolysis ,chemistry.chemical_compound ,Exon ,Internal medicine ,Report ,Genotype ,medicine ,Genetics ,Humans ,Genetics(clinical) ,Genetic Predisposition to Disease ,Myopathy ,Child ,Genetics (clinical) ,Mutation ,Models, Genetic ,business.industry ,Muscles ,Myoglobinuria ,Nuclear Proteins ,Phosphatidic acid ,Exons ,Disease gene identification ,medicine.disease ,Pedigree ,Endocrinology ,chemistry ,Haplotypes ,Female ,medicine.symptom ,Erratum ,business - Abstract
Recurrent episodes of life-threatening myoglobinuria in childhood are caused by inborn errors of glycogenolysis, mitochondrial fatty acid beta-oxidation, and oxidative phosphorylation. Nonetheless, approximately half of the patients do not suffer from a defect in any of these pathways. Using homozygosity mapping, we identified six deleterious mutations in the LPIN1 gene in patients who presented at 2–7 years of age with recurrent, massive rhabdomyolysis. The LPIN1 gene encodes the muscle-specific phosphatidic acid phosphatase, a key enzyme in triglyceride and membrane phospholipid biosynthesis. Of six individuals who developed statin-induced myopathy, one was a carrier for Glu769Gly, a pathogenic mutation in the LPIN1 gene. Analysis of phospholipid content disclosed accumulation of phosphatidic acid and lysophospholipids in muscle tissue of the more severe genotype. Mutations in the LPIN1 gene cause recurrent rhabdomyolysis in childhood, and a carrier state may predispose for statin-induced myopathy.
- Published
- 2008
- Full Text
- View/download PDF